SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-19-007743
Filing Date
2019-04-26
Accepted
2019-04-26 17:27:55
Documents
5
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEFA14A nc10001182x2_defa14a.htm DEFA14A 29510
2 nc10001182x2_notice01.jpg GRAPHIC 132864
3 nc10001182x2_notice02.jpg GRAPHIC 197138
4 nc10001182x2_notice03.jpg GRAPHIC 25048
5 nc10001182x2_notice04.jpg GRAPHIC 16695
  Complete submission text file 0001140361-19-007743.txt   537435
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38470 | Film No.: 19772970
SIC: 2834 Pharmaceutical Preparations